Knee injury: evaluation of biological Factors and Clinical Trials Study

niversity of Nottingham0 个研究点目标入组 80 人开始时间: 2024年7月11日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•1. Adult patients (>17 years old, no maximum age) who attend Nottingham University Hospitals under the care of orthopaedic trauma and are undergoing treatment for intraarticular knee injuries. Must include one or more of the injury groups outlined below and include an intraarticular component as defined in AO Classification (2018):
•1.1. Patella fracture
•1.2. Tibial plateau fracture
•1.3. Distal femur fracture
•2. Able to give informed consent
•3. Able to complete required questionnaires

•1. Aged 17 years or under
•2. Concomitant fracture involving another joint
•3. Taking anticoagulants (direct oral anticoagulants [DOACs], warfarin) or coagulopathy
•4. Intra articular knee fracture that involves preceding prosthesis or implant.
•5. Significant soft tissue injury making aspiration not feasible or safe as determined by one of the investigative team
•6. Presence of local (knee) or systemic infection
•7. Immunomodulating medication or treatments with systemic impact
•8. Systemic chronic inflammatory diseases
•9. Active malignancy
•10. Pregnancy or breastfeeding
•11. People in the custody of the police or incarcerated persons
•12. Inability to read or write English.
•13. People with significant mental health disease under section

发起方

niversity of Nottingham